Nonsurgical spinal decompression carries mostly low, temporary risks (soreness, symptom flares, and rare device-related injuries), while surgical decompression carries genuine surgical risks, including infection, bleeding, and nerve damage. The gap between these two risk profiles is wide, and it matters enormously which one you’re actually considering.
Before you commit to either path, a few things deserve your attention. Independent literature reviews have found that evidence for nonsurgical device-based decompression rests on studies that are frequently small, uncontrolled, or tied to the companies selling the equipment. That doesn’t make the treatment dangerous. It does mean you should treat marketing promises with more skepticism than you’d apply to a well-studied surgical procedure. At Shephard Health, screening starts before any device touches your spine.
Spinal decompression risk depends far more on proper candidate screening and provider judgment than on whether you choose the surgical or nonsurgical route.
| Point | Details |
|---|---|
| Nonsurgical risk is generally low | Expect temporary soreness or symptom flares; serious device injury is rare but documented. |
| Surgical risk is real but manageable | Infection, bleeding, nerve injury, and anesthesia complications require an experienced surgical team. |
| Evidence for devices remains limited | Independent reviews cite small, uncontrolled, or industry-linked studies behind many marketing claims. |
| Screening rules out dangerous candidates | Imaging and a neurological exam should precede any decompression protocol, surgical or not. |
| Insurance often won’t cover devices | Insufficient evidence leads many insurers, including Medicare, to deny coverage for nonsurgical courses. |
If you’re weighing your options, the first-visit process at Shephard Health starts with exactly the kind of screening this article recommends, so you know where you stand before committing to a treatment plan.
This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.
Nonsurgical spinal decompression, the motorized traction table you’ve probably seen advertised for back pain, works by gently stretching the spine to reduce pressure on discs and nerves. The side effects reported most often are mild: temporary soreness after a session, a short-lived flare of your existing symptoms, or muscle stiffness that fades within a day or two. Rare but documented problems include device malfunctions and, in isolated case reports, injuries tied to poorly monitored sessions. The bigger issue isn’t injury. It’s the lack of proof that the benefit outlasts the treatment course.
Surgical spinal decompression, procedures like laminectomy or discectomy, sits in a different risk category entirely. Cleveland Clinic lists the standard surgical complications clearly:
Here’s the number that should reframe your thinking: investigative reporting has documented lawsuits and FDA complaints tied to nonsurgical decompression devices, alongside aggressive marketing that outpaces the science. That’s a very different kind of risk than a scalpel complication, but it’s a risk to your wallet and your treatment timeline nonetheless.
Most people who try nonsurgical decompression experience nothing worse than mild, transient soreness. Serious device-related injury is uncommon. Surgical complications follow a similar pattern: common issues are minor and self-limiting, while severe outcomes are uncommon but carry real weight when they occur.
Here’s the honest caveat: nobody can hand you a precise, reliable incidence rate for either category. High-quality randomized trials on nonsurgical decompression are scarce, and device-related adverse events are frequently underreported to registries. Surgical risk data is more robust, but it still varies by surgeon volume, patient health, and surgery type.
NHS inform offers one of the more transparent breakdowns available, noting that while common surgical complications (infection, minor bleeding) occur at meaningfully higher rates than catastrophic ones, severe events like stroke or death under general anesthesia remain very rare.
Certain conditions rule decompression out entirely, and others simply raise your risk enough to warrant extra caution. Your provider needs to know your full medical history before recommending either surgical or nonsurgical decompression.
Imaging (X-ray or MRI) and a focused neurological exam aren’t optional extras. They’re how a qualified provider rules out these red flags before your first session.
Systematic reviews of nonsurgical spinal decompression consistently point to the same problem: most published studies are small, uncontrolled, or connected to the manufacturers marketing the equipment. That’s not the kind of evidence that should drive a major treatment decision on its own.
The scientific literature supporting advertised claims for non-surgical spinal decompression therapy remains thin, with a pattern of methodologically weak studies that don’t match the confidence of the marketing built around them.
Insurers, including Medicare in many jurisdictions, often decline coverage for decompression devices because the evidence base doesn’t meet their threshold for medical necessity. That single fact tells you a lot about how the broader medical establishment views the technology.
You have more control over your risk than the marketing suggests. It starts with insisting on a real screening process, not a sales pitch.
Pro Tip: Ask your provider to define success before you start, not after you’ve paid for a full course. A responsible clinic will offer a short trial with a scheduled reassessment rather than pushing a large upfront package.
Explore how nonsurgical back pain treatments compare when you’re weighing decompression against exercise-based or manual therapy options.
Nonsurgical decompression trials typically run several weeks, with sessions spaced two to three times a week and a checkpoint to assess whether it’s working. Surgical recovery follows a longer arc: an early postoperative phase focused on wound healing and pain control, followed by gradual activity increases through the 6 to 12 week mark.
Responsible use of spinal decompression starts with candidacy, not the device itself. At Shephard Health, that means individualized treatment plans built around imaging review, a neurological exam, and honest conversation about what decompression can and can’t do for your specific condition.
You can review how the clinic structures this specific service on the spinal decompression page.
The conventional pitch around spinal decompression treats the machine as the hero: newer table, stronger traction, better results. That framing gets the risk equation backward. The device is the least important variable in the room. What actually determines your outcome, and your safety, is whether someone took the time to rule out a fracture, an infection, a tumor, or cauda equina symptoms before you ever laid down on the table.
The evidence gap on nonsurgical decompression isn’t going away soon, and I’d argue it shouldn’t stop you from trying it under the right conditions: short trial, clear stop rules, honest reassessment. What should stop you is a provider who skips the neurological exam and jumps straight to selling you a twenty-session package. Surgical decompression deserves the opposite bias. It’s proven for the right candidates, and the risk conversation there should center on surgeon experience and your own health status, not whether the procedure “works” in principle.
If you take one thing from this, let it be that the question “is this safe for me” always beats “is this safe” in general.
— Deane
Same Day Appointments Available
We Direct Bill!